Status:

UNKNOWN

Hematological Disorders in Covid 19 Patients

Lead Sponsor:

Assiut University

Conditions:

Hematological Abnormalities in covid19

Eligibility:

All Genders

18-90 years

Brief Summary

aim of the research is to detect hematological abnormalities in covid 19 patients and its correlation with the severity and outcome of the disease.

Detailed Description

Covid 19 is an infectious disease caused by a newly discovered coronavirus.most people infected with the covid 19 virus will have mild to moderate respiratory illness and recover without specific trea...

Eligibility Criteria

Inclusion

  • all covid 19 patients diagnosed by pcr or CT chest
  • \-

Exclusion

  • No

Key Trial Info

Start Date :

January 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT05182528

Start Date

January 1 2022

End Date

April 1 2023

Last Update

January 10 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.